Cargando…

Retraction: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223743/ https://www.ncbi.nlm.nih.gov/pubmed/34178702 http://dx.doi.org/10.3389/fonc.2021.709636

Ejemplares similares

Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Case report: Hyperosmolar hyperglycemic syndrome secondary to PEG-asparaginase-induced hypertriglyceridemia and pancreatitis
por: Mudd, Todd William, et al.
Publicado: (2023)

Diabetic ketoacidosis following PEG-asparaginase therapy
por: Ahmad, Miriam Hinaa, et al.
Publicado: (2018)

Peg-Grafted Liposomes for L-Asparaginase Encapsulation
por: de Souza Guimarães, Marina, et al.
Publicado: (2022)

Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication
por: Losasso, Michael, et al.
Publicado: (2020)

Efficacy and safety of endoscopic retrograde cholangiopancreatography in recurrent pancreatitis of pediatric asparaginase-associated pancreatitis
por: Yang, Kai-Hua, et al.
Publicado: (2023)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020)

Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study
por: Liu, Wen-jian, et al.
Publicado: (2016)

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
por: Al Nabhani, Ibrahim, et al.
Publicado: (2022)

L-carnitine and Vitamin B Complex for PEG-L-asparaginase-Induced Hepatotoxicity
por: Arora, Sumant, et al.
Publicado: (2019)

Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice
por: Kumar, Gundala Venkata Naveen, et al.
Publicado: (2021)

Efficacy and safety of PEG-asparaginase versus E. coli L-asparaginase in Chinese children with acute lymphoblastic leukemia: a meta-analysis
por: Dai, Zhan-Jing, et al.
Publicado: (2021)

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine
por: Bollino, Dominique, et al.
Publicado: (2022)

Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination
por: Wang, Yu, et al.
Publicado: (2022)

Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL
por: Sari, Nur Melani, et al.
Publicado: (2023)

Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy
por: Broos, Nancy, et al.
Publicado: (2023)

Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia
por: Zhou, Ruizhi, et al.
Publicado: (2023)

Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
por: Battistel, Ana Paula, et al.
Publicado: (2021)

The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial
por: Masurekar, A, et al.
Publicado: (2014)

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
por: Zheng, Wen, et al.
Publicado: (2017)

Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia
por: Underwood, Brynne, et al.
Publicado: (2020)

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase
por: Yang, Jing, et al.
Publicado: (2022)

Reactions related to asparaginase infusion in a 10-year retrospective cohort
por: Santos, Amanda Cabral dos, et al.
Publicado: (2017)

Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges
por: Gentille, Cesar, et al.
Publicado: (2017)

Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia
por: Iannuzzi, Arcangelo, et al.
Publicado: (2022)

ODP155 Successful Treatment of PEG-Asparaginase Related Hypertriglyceridemia with Omega-3 Acid Ethyl Esters
por: Radovanovic, Natasa, et al.
Publicado: (2022)

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
por: Broggi, Sara, et al.
Publicado: (2023)

Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
por: Aggarwal, Sahil, et al.
Publicado: (2013)

Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
por: Zhang, Xianbin, et al.
Publicado: (2018)

Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study
por: Gupta, Amol, et al.
Publicado: (2023)

Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study
por: Morimoto, Kenji, et al.
Publicado: (2021)

Affordable and Safe Health Care for All Children: Lessons Learned from the Use of Peg-asparaginase in a Developing Country
por: Jayaraman, Dhaarani, et al.
Publicado: (2017)

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
por: M'harzi, Soulaimane, et al.
Publicado: (2022)

PB1742: FEASIBILITY AND EFFICACY OF A PEG-ASPARAGINASE-BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
por: Vernarecci, Chiara, et al.
Publicado: (2023)

Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation
por: Sun, Kai, et al.
Publicado: (2018)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
por: Sassen, Sebastiaan D.T., et al.
Publicado: (2017)

Retrospective Review of Flexible Bronchoscopy in Pediatric Cancer Patients
por: Ahmad, Ali H., et al.
Publicado: (2021)

Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
por: Rank, Cecilie U., et al.
Publicado: (2020)

Complete remission of Hodgkin’s lymphoma in a pediatric patient with TTN gene mutation treated with brentuximab vedotin combined chemotherapy without anthracyclines: A case report
por: Li, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bm60f5oai3p66do8s37ob0ocq7